back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-06-27 Tx date 2016-06-27 |
$CTX
Crescita Therapeutics Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-418 vol |
9,891 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
35,200 | ||
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
10,309 | ||
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+33,662 vol |
35,200 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
|
-33,662 vol |
14,777 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
|
-14,777 vol |
0 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
97 - Other
|
+4 vol |
48,439 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
-3 vol |
10,309 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+3,810 vol |
48,435 | |
| Filed 2015-09-24 Tx date 2015-09-21 |
$NRI
Nuvo Research Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-9,997
-769 vol $13.00 each |
10,312 | |
| Filed 2015-07-06 Tx date 2015-07-01 |
$NRI
Nuvo Research Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+1,026 vol |
44,625 |